Misbah Baqir

1.4k total citations
67 papers, 789 citations indexed

About

Misbah Baqir is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Misbah Baqir has authored 67 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 21 papers in Physiology and 20 papers in Epidemiology. Recurrent topics in Misbah Baqir's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (25 papers), Vasculitis and related conditions (13 papers) and Sarcoidosis and Beryllium Toxicity Research (11 papers). Misbah Baqir is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (25 papers), Vasculitis and related conditions (13 papers) and Sarcoidosis and Beryllium Toxicity Research (11 papers). Misbah Baqir collaborates with scholars based in United States, Italy and China. Misbah Baqir's co-authors include Jay H. Ryu, Teng Moua, Eunhee S. Yi, Robert Vassallo, Ulrich Specks, Andrew H. Limper, Marta Casal Moura, Clayton T. Cowl, Xiaowen Hu and Thomas E. Hartman and has published in prestigious journals such as PLoS ONE, CHEST Journal and Journal of the American Society of Nephrology.

In The Last Decade

Misbah Baqir

58 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Misbah Baqir United States 17 533 252 181 178 139 67 789
Keishi Sugino Japan 18 820 1.5× 226 0.9× 209 1.2× 190 1.1× 143 1.0× 112 1.1k
Laurent Pérard France 16 248 0.5× 238 0.9× 124 0.7× 214 1.2× 119 0.9× 34 823
Ann Knight Sweden 17 418 0.8× 183 0.7× 68 0.4× 337 1.9× 90 0.6× 30 937
José Valverde Spain 12 388 0.7× 222 0.9× 96 0.5× 309 1.7× 118 0.8× 32 673
Antoine Dossier France 14 207 0.4× 179 0.7× 76 0.4× 201 1.1× 60 0.4× 40 658
Fabı́ola Del Carlo Bernardi Brazil 14 589 1.1× 232 0.9× 72 0.4× 66 0.4× 122 0.9× 44 924
Ko‐Ron Chen Japan 16 662 1.2× 123 0.5× 248 1.4× 583 3.3× 105 0.8× 39 1.1k
Katsunori Shigehara Japan 16 337 0.6× 370 1.5× 221 1.2× 155 0.9× 138 1.0× 31 863
Thomas Barba France 12 199 0.4× 72 0.3× 177 1.0× 289 1.6× 96 0.7× 33 749
Matthieu Groh France 15 214 0.4× 106 0.4× 143 0.8× 324 1.8× 120 0.9× 53 655

Countries citing papers authored by Misbah Baqir

Since Specialization
Citations

This map shows the geographic impact of Misbah Baqir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Misbah Baqir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Misbah Baqir more than expected).

Fields of papers citing papers by Misbah Baqir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Misbah Baqir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Misbah Baqir. The network helps show where Misbah Baqir may publish in the future.

Co-authorship network of co-authors of Misbah Baqir

This figure shows the co-authorship network connecting the top 25 collaborators of Misbah Baqir. A scholar is included among the top collaborators of Misbah Baqir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Misbah Baqir. Misbah Baqir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krishna, R. Vijay, Simon R. Johnson, Ali Ataya, et al.. (2025). Sirolimus Use During Pregnancy in Women with Lymphangioleiomyomatosis. Annals of the American Thoracic Society. 22(11). 1794–1797.
2.
Baqir, Misbah, et al.. (2025). Multifaceted pulmonary manifestations of amyloidosis: state-of-the-art update. Expert Review of Respiratory Medicine. 19(2). 107–120.
3.
Moura, Marta Casal, et al.. (2024). Granulomatosis with polyangiitis with and without antineutrophil cytoplasmic antibodies: a case-control study. Lara D. Veeken. 63(12). 3279–3288. 3 indexed citations
4.
Ho, Lawrence, Nishant Gupta, Joel Moss, et al.. (2024). Unsupervised Exercise in Interstitial Lung Disease. CHEST Journal. 166(5). 1108–1123. 2 indexed citations
5.
Villalba, Julian A., et al.. (2024). Vaping-associated constrictive bronchiolitis. Respiratory Medicine Case Reports. 51. 102062–102062. 1 indexed citations
6.
Banydeen, Rishika, Antoine Deney, Jay H. Ryu, et al.. (2023). Risk Stratification in Transthyretin Cardiac Amyloidosis: The Added Value of Lung Spirometry. Journal of Clinical Medicine. 12(11). 3684–3684. 2 indexed citations
7.
Matson, Scott M., Misbah Baqir, Teng Moua, et al.. (2022). Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease. CHEST Journal. 163(4). 861–869. 43 indexed citations
8.
Hartman, Thomas E., et al.. (2022). Clinical, radiologic, and pathologic features and outcomes of pulmonary transthyretin amyloidosis. Respiratory Medicine. 194. 106761–106761. 5 indexed citations
9.
Moura, Marta Casal, Misbah Baqir, Abhishek A. Mangaonkar, et al.. (2022). POS1377 LUNG INVOLVEMENT IN VEXAS SYNDROME. Annals of the Rheumatic Diseases. 81. 1028–1028. 2 indexed citations
10.
Petnak, Tananchai, Charat Thongprayoon, Misbah Baqir, Jay H. Ryu, & Teng Moua. (2022). Antigen identification and avoidance on outcomes in fibrotic hypersensitivity pneumonitis. European Respiratory Journal. 60(4). 2101336–2101336. 16 indexed citations
11.
12.
Moura, Marta Casal, María V. Irazabal, Alfonso Eirin, et al.. (2020). Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis with Severe Kidney Disease. Journal of the American Society of Nephrology. 31(11). 2688–2704. 49 indexed citations
13.
Moura, Marta Casal, Patrick J. Navin, Geoffrey B. Johnson, et al.. (2020). Pulmonary nodules in patients with primary Sjögren's syndrome: Causes, clinico-radiologic features, and outcomes. Respiratory Medicine. 174. 106200–106200. 3 indexed citations
14.
15.
Koslow, Matthew, Jason R. Young, Eunhee S. Yi, et al.. (2018). Rheumatoid pulmonary nodules: clinical and imaging features compared with malignancy. European Radiology. 29(4). 1684–1692. 27 indexed citations
16.
Baqir, Misbah, Darin White, & Jay H. Ryu. (2018). Emphysematous changes in hypersensitivity pneumonitis: A retrospective analysis of 12 patients. Respiratory Medicine Case Reports. 24. 25–29. 15 indexed citations
17.
Moua, Teng, et al.. (2018). Treatment of acute exacerbations of interstitial lung disease. Expert Review of Respiratory Medicine. 12(4). 309–313. 11 indexed citations
18.
Kelm, Diana J., Darin White, Hind J. Fadel, et al.. (2017). Pulmonary manifestations of Q fever: analysis of 38 patients. Journal of Thoracic Disease. 9(10). 3973–3978. 4 indexed citations
19.
Baqir, Misbah, Val J. Lowe, Eunhee S. Yi, & Jay H. Ryu. (2014). 18F-FDG PET Scanning in Pulmonary Amyloidosis. Journal of Nuclear Medicine. 55(4). 565–568. 22 indexed citations
20.
Baqir, Misbah, Chiung‐Zuei Chen, Richard J. Martin, et al.. (2008). Cigarette smoke decreases MARCO expression in macrophages: Implication in Mycoplasma pneumoniae infection. Respiratory Medicine. 102(11). 1604–1610. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026